Cowen Prime Services LLC lowered its position in Invuity, Inc. (NASDAQ:IVTY) by 34.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 299,050 shares of the medical instruments supplier’s stock after selling 158,500 shares during the period. Cowen Prime Services LLC owned approximately 1.74% of Invuity worth $1,854,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also recently made changes to their positions in IVTY. CAPROCK Group Inc. raised its stake in shares of Invuity by 28.6% during the third quarter. CAPROCK Group Inc. now owns 45,000 shares of the medical instruments supplier’s stock valued at $401,000 after acquiring an additional 10,000 shares in the last quarter. OxFORD Asset Management LLP purchased a new position in Invuity during the second quarter valued at approximately $374,000. Vanguard Group Inc. increased its holdings in Invuity by 16.3% during the second quarter. Vanguard Group Inc. now owns 402,680 shares of the medical instruments supplier’s stock valued at $2,919,000 after buying an additional 56,527 shares during the period. Discovery Group I LLC increased its holdings in Invuity by 9,587.9% during the third quarter. Discovery Group I LLC now owns 1,258,849 shares of the medical instruments supplier’s stock valued at $11,204,000 after buying an additional 1,245,855 shares during the period. Finally, Lyon Street Capital LLC increased its holdings in Invuity by 5.2% during the second quarter. Lyon Street Capital LLC now owns 764,530 shares of the medical instruments supplier’s stock valued at $5,543,000 after buying an additional 37,498 shares during the period. 67.57% of the stock is owned by institutional investors and hedge funds.
Several equities analysts have issued reports on the stock. Zacks Investment Research raised shares of Invuity from a “hold” rating to a “buy” rating and set a $6.00 price target on the stock in a report on Saturday, January 27th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $12.00 price target on shares of Invuity in a report on Friday, November 10th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $10.25.
Invuity, Inc. (NASDAQ IVTY) traded up $0.50 during trading hours on Tuesday, hitting $4.50. 277,400 shares of the stock traded hands, compared to its average volume of 277,127. Invuity, Inc. has a 1-year low of $3.75 and a 1-year high of $9.70. The company has a debt-to-equity ratio of 5.39, a current ratio of 2.90 and a quick ratio of 2.47.
COPYRIGHT VIOLATION NOTICE: This piece was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States and international copyright and trademark law. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/13/cowen-prime-services-llc-has-1-85-million-stake-in-invuity-inc-ivty.html.
Invuity Company Profile
Invuity, Inc, a medical technology company, develops various surgical devices to address various surgical procedures in the United States. The company integrates its intelligent photonics technology platform into its single-use and reusable advanced surgical devices to address various critical intracavity illumination and visualization challenges.
Receive News & Ratings for Invuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invuity and related companies with MarketBeat.com's FREE daily email newsletter.